Gam Holding Ag United Therapeutics Corp Transaction History

Gam Holding Ag

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 12, 2019	SELL	$76.06 - $120.81 $573,796 - $911,390	-7,544 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$107.15 - $126.84 $505,855 - $598,811	4,721 Added 167.23%	7,544 $885,000
Q4 2018 Feb 08, 2019	SELL	$101.4 - $128.73 $321,640 - $408,331	-3,172 Reduced 52.91%	2,823 $307,000
Q3 2018 Nov 13, 2018	SELL	$113.81 - $129.46 $178,226 - $202,734	-1,566 Reduced 20.71%	5,995 $767,000
Q2 2018 Aug 09, 2018	SELL	$101.14 - $118.31 $412,550 - $482,586	-4,079 Reduced 35.04%	7,561 $856,000
Q1 2018 May 15, 2018	SELL	$107.21 - $151.94 $957,921 - $1.36 Million	-8,935 Reduced 43.43%	11,640 $1.31 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $2.2 Million - $2.81 Million	18,575 Added 928.75%	20,575 $3.04 Million
Q3 2017 Nov 14, 2017	SELL	$114.6 - $136.81 $1.29 Million - $1.54 Million	-11,289 Reduced 84.95%	2,000 $234,000
Q2 2017 Aug 07, 2017	BUY	N/A	13,289	13,289 $1.72 Million

619

45M

368K

410K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $15.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

Stay updated on Gam Holding Ag with notifications on news.